News
Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...
Despite this setback, VYNE has reported no serious adverse events in the subjects enrolled in the study thus far. VYNE’s leadership expressed their commitment to resolving the clinical hold swiftly ...
17h
PureWow on MSNFacial Cupping Is Back-But Dermatologists Are Begging You to Stop Making These MistakesThe practice of cupping has a long history, going back thousands of years before Michael Phelps showed up at the 2016 ...
Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...
Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...
A new study in Scientific Reports reveals that skin shame is a key psychological burden for people with atopic dermatitis and ...
Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.
THOUGHT you’d nailed your beauty regime? Even if you’re using all the right products, you might still be damaging your health ...
Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.
HONG KONG, China I April 18, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results